Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Young, SG, Fong, LG, Beigneux, AP, Allan, CM, He, C, Jiang, H, Nakajima, K, Meiyappan, M, Birrane, G & Ploug, M 2019, 'GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism' Cell Metabolism, vol. 30, no. 1, pp. 51-65. https://doi.org/10.1016/j.cmet.2019.05.023

APA

Young, S. G., Fong, L. G., Beigneux, A. P., Allan, C. M., He, C., Jiang, H., ... Ploug, M. (2019). GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism. Cell Metabolism, 30(1), 51-65. https://doi.org/10.1016/j.cmet.2019.05.023

CBE

Young SG, Fong LG, Beigneux AP, Allan CM, He C, Jiang H, Nakajima K, Meiyappan M, Birrane G, Ploug M. 2019. GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism. Cell Metabolism. 30(1):51-65. https://doi.org/10.1016/j.cmet.2019.05.023

MLA

Vancouver

Young SG, Fong LG, Beigneux AP, Allan CM, He C, Jiang H et al. GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism. Cell Metabolism. 2019 Jul 2;30(1):51-65. https://doi.org/10.1016/j.cmet.2019.05.023

Author

Young, Stephen G ; Fong, Loren G ; Beigneux, Anne P ; Allan, Christopher M ; He, Cuiwen ; Jiang, Haibo ; Nakajima, Katsuyuki ; Meiyappan, Muthuraman ; Birrane, Gabriel ; Ploug, Michael. / GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism. In: Cell Metabolism. 2019 ; Vol. 30, No. 1. pp. 51-65.

Bibtex

@article{9bd08571c45c41979ebd09b6b24acf7b,
title = "GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism",
abstract = "Lipoprotein lipase (LPL), identified in the 1950s, has been studied intensively by biochemists, physiologists, and clinical investigators. These efforts uncovered a central role for LPL in plasma triglyceride metabolism and identified LPL mutations as a cause of hypertriglyceridemia. By the 1990s, with an outline for plasma triglyceride metabolism established, interest in triglyceride metabolism waned. In recent years, however, interest in plasma triglyceride metabolism has awakened, in part because of the discovery of new molecules governing triglyceride metabolism. One such protein-and the focus of this review-is GPIHBP1, a protein of capillary endothelial cells. GPIHBP1 is LPL's essential partner: it binds LPL and transports it to the capillary lumen; it is essential for lipoprotein margination along capillaries, allowing lipolysis to proceed; and it preserves LPL's structure and activity. Recently, GPIHBP1 was the key to solving the structure of LPL. These developments have transformed the models for intravascular triglyceride metabolism.",
author = "Young, {Stephen G} and Fong, {Loren G} and Beigneux, {Anne P} and Allan, {Christopher M} and Cuiwen He and Haibo Jiang and Katsuyuki Nakajima and Muthuraman Meiyappan and Gabriel Birrane and Michael Ploug",
note = "Copyright {\circledC} 2019 Elsevier Inc. All rights reserved.",
year = "2019",
month = "7",
day = "2",
doi = "10.1016/j.cmet.2019.05.023",
language = "English",
volume = "30",
pages = "51--65",
journal = "Cell Metabolism",
issn = "1550-4131",
publisher = "Cell Press",
number = "1",

}

RIS

TY - JOUR

T1 - GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism

AU - Young, Stephen G

AU - Fong, Loren G

AU - Beigneux, Anne P

AU - Allan, Christopher M

AU - He, Cuiwen

AU - Jiang, Haibo

AU - Nakajima, Katsuyuki

AU - Meiyappan, Muthuraman

AU - Birrane, Gabriel

AU - Ploug, Michael

N1 - Copyright © 2019 Elsevier Inc. All rights reserved.

PY - 2019/7/2

Y1 - 2019/7/2

N2 - Lipoprotein lipase (LPL), identified in the 1950s, has been studied intensively by biochemists, physiologists, and clinical investigators. These efforts uncovered a central role for LPL in plasma triglyceride metabolism and identified LPL mutations as a cause of hypertriglyceridemia. By the 1990s, with an outline for plasma triglyceride metabolism established, interest in triglyceride metabolism waned. In recent years, however, interest in plasma triglyceride metabolism has awakened, in part because of the discovery of new molecules governing triglyceride metabolism. One such protein-and the focus of this review-is GPIHBP1, a protein of capillary endothelial cells. GPIHBP1 is LPL's essential partner: it binds LPL and transports it to the capillary lumen; it is essential for lipoprotein margination along capillaries, allowing lipolysis to proceed; and it preserves LPL's structure and activity. Recently, GPIHBP1 was the key to solving the structure of LPL. These developments have transformed the models for intravascular triglyceride metabolism.

AB - Lipoprotein lipase (LPL), identified in the 1950s, has been studied intensively by biochemists, physiologists, and clinical investigators. These efforts uncovered a central role for LPL in plasma triglyceride metabolism and identified LPL mutations as a cause of hypertriglyceridemia. By the 1990s, with an outline for plasma triglyceride metabolism established, interest in triglyceride metabolism waned. In recent years, however, interest in plasma triglyceride metabolism has awakened, in part because of the discovery of new molecules governing triglyceride metabolism. One such protein-and the focus of this review-is GPIHBP1, a protein of capillary endothelial cells. GPIHBP1 is LPL's essential partner: it binds LPL and transports it to the capillary lumen; it is essential for lipoprotein margination along capillaries, allowing lipolysis to proceed; and it preserves LPL's structure and activity. Recently, GPIHBP1 was the key to solving the structure of LPL. These developments have transformed the models for intravascular triglyceride metabolism.

U2 - 10.1016/j.cmet.2019.05.023

DO - 10.1016/j.cmet.2019.05.023

M3 - Review

VL - 30

SP - 51

EP - 65

JO - Cell Metabolism

JF - Cell Metabolism

SN - 1550-4131

IS - 1

ER -

ID: 57758556